LUPELIC
Live / Registered — Registered (as of 17 Jun 2025)
What this means for you
Registered since 17 Jun 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98956801
- Registration number
- 7836182
- Mark type
- Stylized text
- Filed
- 13 Jan 2025
- Published for opposition
- 29 Apr 2025
- Registered
- 17 Jun 2025
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 17 Jun 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Jun 2025 — REGISTERED-PRINCIPAL REGISTER
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Mar 2025 — ASSIGNED TO EXAMINER
- 13 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Jan 2025 — NEW APPLICATION ENTERED